¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-09-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-09-01  
±³À°ÀÏÀÚ : 2018-09-01
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ¸¶¸®¾ÆȦ  
±³À°ÁÖÁ¦ : 2018 KPS-APSU Joint International Symposium      
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢±â°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀü¸³¼±ÇÐȸ  
´ã´çÀÚ : È«¼º±Ô
¿¬¶ôó : 02-556-7473  
À̸ÞÀÏ : soyeon@iztec.co.kr      
±³À°Á¾·ù : ºñ´¢±â°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í »çÀüµî·Ï (6/1~8/20) ÀÇ»ç 10¸¸¿ø / °£È£»ç ±× ¿Ü 7¸¸¿ø ÇöÀåµî·Ï (8/31~9/1) ÀÇ»ç 15¸¸¿ø / °£È£»ç ±× ¿Ü 7¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:00~09:15 Management of Lymph node-positive penile cancer  ÀåÀÎÈ£(Áß¾Ó´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:15~09:30 Contemporary retroperitoneal lymph node dissection for testis cancer  ½É¸í¼±(ÇѸ²´ë¼º½Éº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:30~09:45 Tamsulosin 0.4mg use in Asian Patients  ÇÏÀ¯½Å(¼­¿ï¼º¸ðº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 09:45~10:00 Panel Discussion  Stephen J. Freedland (USA)Lukman Hakim (Indonesia)Á¤Å¿µPeter Mulders (Netherlands)ÇãÁ¤½ÄGiuseppe Procopio (Italy)¹Ú½ÂöBannakij Lojanapiwat (Thailand)(Cedars-Sinai, USAAirlangga UniversityÁß¾Óº¸Èƺ´¿øRadboud University Medical Center Nijmegen, The NetherlandsÁ¦ÁÖ´ëÇб³º´¿øFondazione Istituto Nazionale Tumori, Milan, Italy¿ø±¤´ëÇб³º´¿øFaculty of Medicine, Chiang Mai University, Chiang Mai, Thailand) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 10:20~10:35 Focal therapy elilgibility determined by mpMRI or mpMRI/US fusion Biopsy  ÀüȲ±Õ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 10:35~10:55 Molecular imaging in the management of prostate cancer  Robert Reiter (USA)(UCLA, USA) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 10:55~11:15 How to manage node-positive prostate cancer  ÇÏÈ«±¸(ºÎ»ê´ëº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 11:15~11:30 Practical Guidance on the comorbidity in the treatment of mCRPC  Á¤À翵(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 12:40~13:00 Optimalization of imaging in renal tumors: use of CAIX antibody  Peter Mulders (Netherlands)(Radboud University Medical Center Nijmegen, The Netherlands) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:00~13:15 The role of arterial embolization in RCCa  ±èÇöÅÂ(Ä¥°î°æºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:15~13:30 Indication of renal biopsy in renal tumors  Á¤Àΰ©(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:30~13:50 Current strategies and future challenges in 2nd line therapy in advanced RCC   Giuseppe Procopio (Italy)(Fondazione Istituto Nazionale Tumori, Milan, Italy) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 13:50~14:00 Panel Discussion  ¼Û丰Lukman Hakim (Indonesia)È«¼ºÈÄRobert Reiter (USA)°íÁؼºBannakij Lojanapiwat (Thailand)ÀÓÀ缺Stephen J. Freedland (USA)(¼­¿ï¾Æ»êº´¿øAirlangga University¼­¿ï¼º¸ðº´¿øUCLA, USAºÎõ¼º¸ðº´¿øFaculty of Medicine, Chiang Mai University, Chiang Mai, ThailandÃæ³²´ëº´¿øCedars-Sinai, USA) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 14:20~14:40 NMIBC BCG unresponsive disease   Seth Lerner (USA)(Baylor College of Medicine, USA) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 14:40~14:55 Urine Markers for Bladder Cancer  À±¼®Áß(ÃæºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 14:55~15:10 Enhanced Technique Endoscopic Visualization in NMIBC  °­¼®È£(°í´ë ¾È¾Ïº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 15:10~15:25 Role of IO in NMIBC  ¼­È£°æ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 15:40~16:00 Neoadjuvant treatment prior to prostatectomy in High-Risk Disease  À¯´Þ»ê(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:00~16:15 Local Treatment in Patients with Newly Diagnosed Metastatic Disease: Myth or Reality?  ±Ç¼¼À±(µ¿±¹´ë°æÁÖº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:15~16:30 Current management of hormone sensitive prostate cancer  À̽Âȯ(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:30~16:50 CRPC: definition and treatment options  Stephen J. Freedland (USA)(Cedars-Sinai, USA) 
±³À°½Ã°£ 09¿ù 01ÀÏ ¸¶¸®¾ÆȦ 16:50~17:00 Panel Discussion  Shigeo Horie (Japan)Seth Lerner (USA)È­Á¤¼®Hideyuki Akaza (Japan)±è¼±ÀÏLukman Hakim (Indonesia)±è¼öµ¿Rainy Umbas (Indonesia)°í¿µÈÖÀÌ»óÀº(Graduate School of Medicine, Juntendo University, Tokyo, JapanBaylor College of Medicine, USA°æ»ó´ëÇб³º´¿øResearch Center for Advanced Science and Technology, University of Tokyo, Japan¾ÆÁÖ´ëÇб³º´¿øAirlangga Universityµ¿¾Æ´ëÇб³º´¿øUniversity of Indonesia¿µ³²´ëÇб³º´¿øºÐ´ç¼­) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-09-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°£ÇÐȸ °£Áúȯ ÃֽŠÁö°ß update : 2018-09-01
´ÙÀ½±Û ´ëÇѽŻý¾ÆÇÐȸ Á¦9Â÷ ±³À°¼¼¹Ì³ª ¥± : 2018-09-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20868 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 7 2024-05-27
20867 ¼­¿ï ´ëÇÑ°£ÇÐȸ The Liver Week 2024 Day 1 : 2024-06-27 0 6 2024-05-27
20866 °æ±â ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Áö¿ª»çȸ Á¤½Å°Ç°­ ÁõÁøÀ» À§ÇÑ Ä¡·áÀû Á¢±Ù : 2024-06-26 0 12 2024-05-27
20865 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-06-26 0 9 2024-05-27
20864 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À°(¿¬¸íÀÇ·á°áÁ¤Á¦µµÀÇ ½ÇÁ¦) : 2024-06-26 0 9 2024-05-27
20863 °æ±â °¡Å縯´ëÇб³ÀÇÁ¤ºÎ¼º¸ðº´¿ø °æ±âºÏºÎ °³¿øÀÇ Áý´ãȸ : 2024-06-25 0 14 2024-05-27
20862 ºÎ»ê ´ëÇѳ»ºÐºñÇÐȸ ºÎ¿ï°æÁöȸ 6¿ù Á¤±âÁý´ãȸ : 2024-06-25 0 15 2024-05-27
20861 ¼­¿ï ±¤Áø±¸ÀÇ»çȸ Á¦1Â÷ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-25 0 6 2024-05-27
20860 °æ±â 2024³â ¾È»ê½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-25 0 7 2024-05-27
20859 °æ±â ½ÃÈï½ÃÀÇ»çȸ Àü¹Ý±â ¿¬¼ö±³À° : 2024-06-24 0 8 2024-05-27
20858 ´ë±¸ ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ Sports Medicine Symposium 2024 in Daegu : 2024-06-23 0 12 2024-05-27
20857 ¼­¿ï 2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦12Â÷ Clinical Densitometry Course : 2024-06-23 0 18 2024-05-27
20856 ¼­¿ï Á¦5ȸ ´ëÇÑ´ÜÀÏ°ø¼ö¼úÇÐȸ Çмú´ëȸ : 2024-06-23 0 8 2024-05-27
20855 ¿ï»ê 2024 ¿ï»ê´ëÇб³º´¿ø Á¦22ȸ ³»°ú ¿¬¼ö°­Á : 2024-06-23 0 40 2024-05-27
20854 °æ±â 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ °æ±â³²ºÎÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 9 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷